Register now for a personalized educational experience.
Already a member? Log In
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
Historically, treatment options for patients with severe aortic stenosis have been limited to surgical valve replacement and medical therapy. Transcatheter aortic valve replacement (TAVR), also known as transcatheter aortic valve implantation (TAVI), is a less invasive approach that allows for aortic valve implantation for patients with severe aortic stenosis who are at increased surgical risk or have been turned down for traditional aortic valve replacement because of age or other medical conditions.
Since many patients with severe aortic stenosis are at increased surgical risk and have considerable mortality in the short term, TAVR may provide a treatment pathway that would otherwise be unavailable. Unfortunately, the proportion of our patients that are less-than-ideal surgical candidates only continues to increase. Although not without risks, transcatheter aortic valve replacement is a promising alternative for this population, and we are fortunate to be able to provide patients with potential access to this option.
We're also among an exclusive group of hospitals with experience in these and other clinical trials:
Please call the UPMC Center for Aortic Valve Disease at 412-647-1621 for scheduling or email ValveCenter@upmc.edu. We also are available to discuss the benefits of this procedure for your specific patients. Lisa Henry DNP CRNP, Clinical Project Director is also available to discuss the benefits of this procedure for your specific patients at 1-888-412-VALV (+1-888-412-8258)